FDA Approves Concussion Blood Test but Concerns Remain
On February 14, 2018, the federal Food and Drug Administration (FDA) approved usage of a ground-breaking blood test that can diagnose concussion in patients who have suffered head injuries. According to NBC News, the primary advantage of the test is that the victim obtains a faster, more accurate diagnosis without the need of exposure to radiation. The test will be most useful in cases in which there is some doubt as to whether the individual has suffered a concussion, such as after a car accident when the victim does not show obvious signs.
FDA Approves Concussion Blood Test but Concerns Remain Read More »
